Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.3.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used